Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
India GlycolsBOM:500201 +0.36%67 Cyclically Adjusted PS Ratio is 1.79 as of Aug. 16, 2026, which is 9% above its 10-year median of 1.64. GuruFocus rates BOM:500201 with a GF Score™ of 67/100 and a GF Value™ of ₹795.07 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 1,274 Chemicals companies, India Glycols ranks worse than 58.87% on this metric.
The historical rank and industry rank for India Glycols's Cyclically Adjusted PS Ratio or its related term are showing as below:
BOM:500201'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.96 Med: 1.64 Max: 1.98
Current: 1.79
During the past years, India Glycols's highest Cyclically Adjusted PS Ratio was 1.98. The lowest was 0.96. And the median was 1.64.
BOM:500201's Cyclically Adjusted PS Ratio is ranked worse than 58.87% of 1274
companies
in the Chemicals industry
Industry Median: 1.345
vs BOM:500201: 1.79
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
India Glycols's adjusted revenue per share data for the three months ended in Jun. 2026 was ₹168.690. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹590.34 for the trailing ten years ended in Jun. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
India Glycols (BOM:500201) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
India Glycols Cyclically Adjusted PS Ratio Related Terms
India Glycols Cyclically Adjusted PS Ratio Historical Data
* Premium members only.
The historical data trend for India Glycols's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:500201 vs DOW: Cyclically Adjusted PS Ratio Comparison
For the Chemicals subindustry, India Glycols's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
India Glycols Cyclically Adjusted PS Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, India Glycols's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where India Glycols's Cyclically Adjusted PS Ratio falls into.
India Glycols Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
India Glycols's Cyclically Adjusted PS Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 1.79 mean?
India Glycols (BOM:500201) has a Cyclically Adjusted PS Ratio of 1.79 as of Aug. 16, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on India Glycols and its competitors. This is near median its historical median of 1.64. Over the past decade, India Glycols' Cyclically Adjusted PS Ratio has ranged from 0.96 to 1.98. According to the industry distribution chart, India Glycols ranks #750 out of 1274 companies in the Chemicals industry, placing it in the top 58.9%.
Is India Glycols' Cyclically Adjusted PS Ratio too high?
India Glycols' current Cyclically Adjusted PS Ratio of 1.79 is near median its 10-year median of 1.64. Over the past 10 years, this metric has ranged from a low of 0.96 to a high of 1.98. The Chemicals industry median Cyclically Adjusted PS Ratio is 1.35. India Glycols' value of 1.79 is 33.1% above this industry median. Based on the distribution chart, India Glycols ranks #750 out of 1274 companies in the Chemicals industry, which is below the industry midpoint. Overall, India Glycols has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does India Glycols' Cyclically Adjusted PS Ratio compare to DOW?
According to the Chemicals industry distribution chart, India Glycols ranks #750 out of 1274 companies for Cyclically Adjusted PS Ratio. This places India Glycols in the lower half of its industry. The industry median Cyclically Adjusted PS Ratio is 1.35. India Glycols' value of 1.79 is 33.1% above this benchmark. Historically, India Glycols' own Cyclically Adjusted PS Ratio has ranged from 0.96 to 1.98 over the past decade. While the company's 10-year median is 1.64 vs. the industry median of 1.35, India Glycols has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Chemicals company?
The median Cyclically Adjusted PS Ratio among Chemicals companies is 1.35, based on 1,274 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. India Glycols's current Cyclically Adjusted PS Ratio of 1.79 is 33.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on India Glycols and its competitors. For the Chemicals industry, the median Cyclically Adjusted PS Ratio is 1.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. India Glycols's current Cyclically Adjusted PS Ratio is 1.79, which is near median its own 10-year median of 1.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is India Glycols stock overvalued right now?
Based on GuruFocus' analysis, India Glycols (BOM:500201) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹795.07, compared to a current price of ₹1,058.35 — trading 33.1% above its estimated fair value. The current Cyclically Adjusted PS Ratio is 1.79, which is near median its 10-year median of 1.64 and 33.1% above the Chemicals industry median of 1.35. India Glycols' overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For India Glycols (BOM:500201), the current Cyclically Adjusted PS Ratio is 1.79 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is India Glycols (BOM:500201) Overvalued in 2026?
Based on GuruFocus' analysis, India Glycols stock appears to be overvalued.
The current stock price of ₹1,058.35 is trading 33.1% above its estimated GF Value™ of ₹795.07.
GuruFocus considers India Glycols to be Significantly Overvalued.
Key valuation signals for BOM:500201:
Cyclically Adjusted PS Ratio: 1.79 (near median its 10-year median of 1.64)
GF Value™: ₹795.07 vs. price of ₹1,058.35 (33.1% above fair value)
Industry Position: 33.1% above the Chemicals median (#750 of 1274)
No single metric tells the full story. See the BOM:500201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
India Glycols Ltd is engaged in the manufacture of Bio-Based Specialities and Performance Chemicals, such as green technology-based bulk products, natural gums, and industrial gases; Potable Spirits, and Ennature Biopharma. The company operates through industries of Pharma & Healthcare, Oil & Gas, Textile, Food Ingredients, Automotive, Packaging, Personal Care, Potable Spirits, and Industrial and Manufacturing. Its operating segments are Bio-based Specialities and Performance Chemicals comprise Glycols, Specialty Chemicals, Natural Gum & other related goods, etc; Potable Spirits comprises the manufacture and sale of Ethyl Alcohol (Potable); Ennature Biopharma comprises the manufacture and sale of Nutraceutical Products; and Bio-fuel comprises Ethanol, DDGS & DWGS.
67GF Score
Get the complete analysis for BOM:500201
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500201 has been successfully added to your 
